Latest Articles

Article Type

You have access
Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys
David R. Maguire

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 155-162; DOI: https://doi.org/10.1124/jpet.122.001318
You have access
Regulation of Ferroptosis by Non-Coding RNAs: Mechanistic Insights
Ammad Ahmad Farooqi, Gulnara Kapanova, Sundetgali Kalmakhanov, Abay Z. Kussainov and Zaure Datkhayeva

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 20-27; DOI: https://doi.org/10.1124/jpet.121.001225
Open Access
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Gavin M. Traber and Ai-Ming Yu

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 133-154; DOI: https://doi.org/10.1124/jpet.122.001234
You have access
Interplay between Non-Coding RNAs and NRF2 in Different Cancers: Spotlight on MicroRNAs and Long Non-Coding RNAs
İlhan Yaylım, Ammad Ahmad Farooqi, Pelin Telkoparan-Akillilar and Luciano Saso

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 28-34; DOI: https://doi.org/10.1124/jpet.121.000921
You have access
Transport of the Proinflammatory Chemokines C-C Motif Chemokine Ligand 2 (MCP-1) and C-C Motif Chemokine Ligand 5 (RANTES) across the Intact Mouse Blood-Brain Barrier Is Inhibited by Heparin and Eprodisate and Increased with Systemic Inflammation
Daniel V. Quaranta, Riley R. Weaver, Kristen K. Baumann, Takashi Fujimoto, Lindsey M. Williams, Hyung Chan Kim, Aric F. Logsdon, Mohamed Omer, May J. Reed, William A. Banks and Michelle A. Erickson

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 205-223; DOI: https://doi.org/10.1124/jpet.122.001380
You have access
Circulating microRNAs as Reliable Tumor Biomarkers: Opportunities and Challenges Facing Clinical Application
Sherien M. El-Daly, Shaimaa A. Gouhar and Zakaria Y. Abd Elmageed

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 35-51; DOI: https://doi.org/10.1124/jpet.121.000896
You have access
Depression of Synaptic N-methyl-D-Aspartate Responses by Xenon and Nitrous Oxide
Naoki Kotani, Il-Sung Jang, Michiko Nakamura, Kiku Nonaka, Hideaki Nagami and Norio Akaike

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 187-196; DOI: https://doi.org/10.1124/jpet.122.001346
You have access
Long Non-Coding RNAs as Cellular Metabolism and Haematopoiesis Regulators
Anjali Sangeeth, Mahesh Malleswarapu, Amit Mishra and Ravi Kumar Gutti

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 79-91; DOI: https://doi.org/10.1124/jpet.121.001120
Open Access
Translational PK/PD Modeling of Tumor Growth Inhibition and Target Inhibition to Support Dose Range Selection of the LMP7 Inhibitor M3258 in Relapsed/Refractory Multiple Myeloma
Floriane Lignet, Christina Esdar, Gina Walter-Bausch, Manja Friese-Hamim, Sofia Stinchi, Elise Drouin, Samer El Bawab, Andreas D. Becker, Claude Gimmi, Michael P. Sanderson and Felix Rohdich

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 163-172; DOI: https://doi.org/10.1124/jpet.122.001355
You have access
The Multiplicity of Argonaute Complexes in Mammalian Cells
Maurizio Mauro, Massimiliano Berretta, Giuseppe Palermo, Vincenzo Cavalieri and Gaspare La Rocca

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 1-9; DOI: https://doi.org/10.1124/jpet.122.001158

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals